home / stock / bhc / bhc news


BHC News and Press, Bausch Health Companies Inc.

Stock Information

Company Name: Bausch Health Companies Inc.
Stock Symbol: BHC
Market: NYSE
Website: bauschhealth.com

Menu

BHC BHC Quote BHC Short BHC News BHC Articles BHC Message Board
Get BHC Alerts

News, Short Squeeze, Breakout and More Instantly...

BHC - Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024

LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...

BHC - How to Take Advantage of moves in (BHC)

2024-07-10 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BHC - Bausch files patent suit against Norwich over generic Xifaxan

2024-06-20 18:11:15 ET More on Bausch Health Companies Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results Bausch Health Companies (BHC) Q1 2024 Earnings Call Transcript Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation ...

BHC - Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals

LAVAL, QC / ACCESSWIRE / June 20, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") and its gastroenterology business, Salix Pharmaceuticals, today announced that it has filed a patent infringement lawsuit in the U.S. District Court for the District of Ne...

BHC - (BHC) Investment Report

2024-06-20 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BHC - Tracking John Paulson's Paulson & Company Portfolio - Q1 2024 Update

2024-06-17 21:24:55 ET Summary Paulson's 13F portfolio value increased to ~$1.45B with 18 securities, top positions include Madrigal Pharma and Bausch Health. John Paulson is known for his leveraged bets against the real-estate bubble, and converted to a Family Office structure in...

BHC - Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences

LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, recently presented at two global healthcare conferences. Bausch Health's gastroente...

BHC - Tracking Carl Icahn's 13F Report - Q1 2024 Update

2024-06-09 10:44:45 ET Summary Carl Icahn's 13F filing shows 14 holdings, including Icahn Enterprises, CVR Energy, Southwest Gas Holdings, Occidental Petroleum warrants, and Bausch Health. Icahn established a new stake in JetBlue Airways this quarter. Also, a significant position ...

BHC - Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults

LAVAL, QC / ACCESSWIRE / May 23, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced additional Canadian public drug plan listings for Pr UCERIS ® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in ad...

BHC - Bausch + Lomb Corporation: Spin-Off Ready To Fly Troubled Nest And Find Upside

2024-05-22 16:31:48 ET Summary Bausch + Lomb, a spin-off from Bausch Health, has shown solid performance with revenues of $4.1bn in 2023 and a narrowing net loss of $(260m). The company's Q1 2024 report shows growth in all segments, including Vision Care, Surgical, and Pharmaceuti...

Next 10